2024年10月30日,医疗器械龙头企业齐默巴奥米特控股(ZBH.US)股价在盘中出现大涨,一度上涨5.84%,收于109.10美元/股,引发市场广泛关注。出人意料的是,该股大涨竟成为当天这家公司下调年度财务指引后的结果。
具体来看,ZBH当日公布下调了2024年财年每股收益预期至7.95-8.05美元区间,较之前预测的8.00-8.15美元有所下调。同时公司也将2024年全年营收增长预期从4%-5%调低至3.5%-4%。
尽管公司下调了年度指引,但实际数字却好于分析师预期。多家分析机构认为,影响并不太大。贝尔德(Baird)指出,下调每股收益预期的影响并未引发市场担忧;RBC资本市场也表示,修订后的2024年展望略好于预期,公司基本销售额符合最近下调后的共识,而每股收益则高于外界预期。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.